LNAI - Enochian Biosciences Inc
0.2322
-0.129 -55.685%
Share volume: 989,953
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.36
-0.13
-0.36%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 08-20-2024 | 01-07-2025 | 02-19-2025 | 02-19-2025 | 05-15-2025 | 11-14-2025 | 02-17-2026 | |
| Cash flow financing | 2.641 M | 2.467 M | 2.029 M | 2.591 M | 3.584 M | 1.343 M | 950.000 K | |
| Other financing cash flows | -223.945 K | 646.128 K | -223.945 K | -204.000 K | -271.643 K | -271.643 K | 0.000 | |
| Cash flow | -84.361 K | -436.000 | 12.855 K | 0.000 | 632.405 K | 538.947 K | -122.451 K | |
| Net income | -51.214 M | -15.732 M | -44.212 M | -7.252 M | 189.176 K | 2.819 M | -1.799 M | |
| Depreciation | 30.305 K | 31.132 K | 32.385 K | 32.109 K | 31.975 K | 41.522 K | 11.183 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -91.597 K | -53.373 K | 0.000 | 0.000 | -1.464 M | 544.700 K | -1.238 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -152.154 K | -29.821 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 5.294 K | 23.552 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 68.717 K | -92.230 K | 104.000 | 91.193 K | 611.238 K | 532.108 K | -133.163 K |